TriSalus Life Sciences completes warrant exchange, issues 2.1M shares at 0.3 per warrant

TriSalus Life Sciences, Inc.

Issued 2,110,366 shares of common stock in exchange for tendered warrants at a ratio of 0.3 shares per warrant.
Exchange covered public warrants (TLSIW), private placement warrants, and working capital warrants.
Warrant agreement amended with Continental Stock Transfer effective June 26, 2024.
Offer and consent solicitation closed July 1, 2024; Oppenheimer served as dealer manager.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.